Sign In

Login

Password

Forgot Password ? Sign Up

Amantadyna (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Amantadyna" in Polish language version.

refsWebsite
Global rank Polish rank
7doi.org
2nd place
6th place
7nih.gov
4th place
7th place
5rp.pl
1,774th place
24th place
3mp.pl
8,738th place
165th place
2web.archive.org
1st place
1st place
2medonet.pl
low place
878th place
1drugbank.ca
4,294th place
205th place
1scbt.com
low place
5,060th place
1gazetalekarska.pl
low place
8,109th place
1aotm.gov.pl
low place
8,056th place
1interia.pl
1,301st place
15th place
1abm.gov.pl
low place
low place
1ezdrowie.gov.pl
low place
4,812th place

abm.gov.pl

aotm.gov.pl

doi.org

dx.doi.org

  • Javier Mancilla-Galindo i inni, All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: A real-world observational study, „EXCLI journal”, 20, 2021, s. 199–222, DOI: 10.17179/excli2021-3413, PMID: 33628159, PMCID: PMC7898041 [dostęp 2021-12-13] (ang.).
  • Gonzalo Emiliano Aranda-Abreu i inni, Observational study of people infected with SARS-Cov-2, treated with amantadine, „Pharmacological reports: PR”, 72 (6), 2020, s. 1538–1541, DOI: 10.1007/s43440-020-00168-1, PMID: 33040252, PMCID: PMC7547815 [dostęp 2021-12-13] (ang.).
  • Konrad Rejdak, Paweł Grieb, Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment, „Multiple Sclerosis and Related Disorders”, 42, 2020, s. 102163, DOI: 10.1016/j.msard.2020.102163, PMID: 32388458, PMCID: PMC7190496 [dostęp 2021-12-13] (ang.).
  • Paweł Grieb i inni, Amantadine for COVID-19, „Journal of Clinical Pharmacology”, 61 (3), 2021, s. 412–413, DOI: 10.1002/jcph.1802, PMID: 33350472 [dostęp 2021-03-30] (ang.).
  • Sandra P. Smieszek, Bart P. Przychodzen, Mihael H. Polymeropoulos, Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment, „International Journal of Antimicrobial Agents”, 55 (6), 2020, s. 106004, DOI: 10.1016/j.ijantimicag.2020.106004, PMID: 32361028, PMCID: PMC7191300 [dostęp 2021-03-30] (ang.).
  • Gonzalo Emiliano Aranda Abreu i inni, Amantadine as a drug to mitigate the effects of COVID-19, „Medical Hypotheses”, 140, 2020, s. 109755, DOI: 10.1016/j.mehy.2020.109755, PMID: 32361100, PMCID: PMC7182751 [dostęp 2021-04-13] (ang.).
  • Abdul Mannan Baig, Areeba Khaleeq, Hira Syeda, Docking Prediction of Amantadine in the Receptor Binding Domain of Spike Protein of SARS-CoV-2, „ACS Pharmacology & Translational Science”, 3 (6), 2020, s. 1430–1433, DOI: 10.1021/acsptsci.0c00172, PMID: 33344913, PMCID: PMC7737314 [dostęp 2021-04-13] (ang.).

drugbank.ca

ezdrowie.gov.pl

rejestrymedyczne.ezdrowie.gov.pl

gazetalekarska.pl

interia.pl

wydarzenia.interia.pl

medonet.pl

mp.pl

indeks.mp.pl

mp.pl

nih.gov

ncbi.nlm.nih.gov

  • Javier Mancilla-Galindo i inni, All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: A real-world observational study, „EXCLI journal”, 20, 2021, s. 199–222, DOI: 10.17179/excli2021-3413, PMID: 33628159, PMCID: PMC7898041 [dostęp 2021-12-13] (ang.).
  • Gonzalo Emiliano Aranda-Abreu i inni, Observational study of people infected with SARS-Cov-2, treated with amantadine, „Pharmacological reports: PR”, 72 (6), 2020, s. 1538–1541, DOI: 10.1007/s43440-020-00168-1, PMID: 33040252, PMCID: PMC7547815 [dostęp 2021-12-13] (ang.).
  • Konrad Rejdak, Paweł Grieb, Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment, „Multiple Sclerosis and Related Disorders”, 42, 2020, s. 102163, DOI: 10.1016/j.msard.2020.102163, PMID: 32388458, PMCID: PMC7190496 [dostęp 2021-12-13] (ang.).
  • Paweł Grieb i inni, Amantadine for COVID-19, „Journal of Clinical Pharmacology”, 61 (3), 2021, s. 412–413, DOI: 10.1002/jcph.1802, PMID: 33350472 [dostęp 2021-03-30] (ang.).
  • Sandra P. Smieszek, Bart P. Przychodzen, Mihael H. Polymeropoulos, Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment, „International Journal of Antimicrobial Agents”, 55 (6), 2020, s. 106004, DOI: 10.1016/j.ijantimicag.2020.106004, PMID: 32361028, PMCID: PMC7191300 [dostęp 2021-03-30] (ang.).
  • Gonzalo Emiliano Aranda Abreu i inni, Amantadine as a drug to mitigate the effects of COVID-19, „Medical Hypotheses”, 140, 2020, s. 109755, DOI: 10.1016/j.mehy.2020.109755, PMID: 32361100, PMCID: PMC7182751 [dostęp 2021-04-13] (ang.).
  • Abdul Mannan Baig, Areeba Khaleeq, Hira Syeda, Docking Prediction of Amantadine in the Receptor Binding Domain of Spike Protein of SARS-CoV-2, „ACS Pharmacology & Translational Science”, 3 (6), 2020, s. 1430–1433, DOI: 10.1021/acsptsci.0c00172, PMID: 33344913, PMCID: PMC7737314 [dostęp 2021-04-13] (ang.).

rp.pl

scbt.com

datasheets.scbt.com

web.archive.org